On the retention of neurotensin in the ventral tegmental area (VTA) despite destruction of the main neurotensinergic afferents of the VTA - Implications for the organization of forebrain projections to the VTA

Brain Research

Volumn 1087, Issue 1, 2006, Pages 87-104

  Geisler, Stefanie ^a   Zahm, Daniel S ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Connection; Dopamine; Peptide; Psychostimulant drug; Reward

Indexed keywords

IBOTENIC ACID; NEUROTENSIN; TRACER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN REGION; BRAIN STEM; BRAIN TISSUE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FOREBRAIN; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFUSION; LATERAL HYPOTHALAMUS; MALE; MEDIAL PREOPTIC AREA; NERVE CELL; NERVE FIBER TRANSPORT; NERVE TRANSECTION; NONHUMAN; NUCLEUS ACCUMBENS; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RETROGRADE NERVE FIBER TRANSPORT; SENSITIVITY ANALYSIS; SENSORY NERVE; STRUCTURE ANALYSIS; SYNAPTOGENESIS; TISSUE SECTION; VENTRAL TEGMENTUM;

ADRENERGIC AGENTS; ANIMALS; EFFERENT PATHWAYS; EXCITATORY AMINO ACID AGONISTS; FUNCTIONAL LATERALITY; IBOTENIC ACID; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MEDIAL FOREBRAIN BUNDLE; NEUROTENSIN; NUCLEUS ACCUMBENS; OXIDOPAMINE; PHYTOHEMAGGLUTININS; PROSENCEPHALON; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VENTRAL TEGMENTAL AREA; WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE;

ANIMALIA;

EID: 33646874835     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.02.108     Document Type: Article

References (77)

1. Alexander M.J., Miller M.A., Dorsa D.M., Bullock B.P., Melloni R.H., Dobner P.R., and Leeman S.E. Distribution of neurotensin/neuromedin N mRNA in rat forebrain, unexpected abundance in hippocampus and subiculum. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 5202-5206
2. Andrade R., and Aghajanian G.K. Neurotensin selectively activates dopaminergic neurones of the substantia nigra. Abstr.-Soc. Neurosci. 7 (1981) 573
3. Bamford N.S., Zhang H., Schmitz Y., Wu N.P., Cepeda C., Levine M.S., Schmauss C., Zakharenko S.S., Zablow L., and Sulzer D. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42 (2004) 653-663
4. Betancur C., Cabrera R., de Kloet E.R., Pelaprat D., and Rostène W. Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine. Neuropsychopharmacology 19 (1998) 322-332
5. Binder E.B., Kinkead B., Owens M.J., and Nemeroff C.B. Neurotensin and dopamine interactions. Pharmacol. Rev. 53 (2001) 453-486
6. Bjijou Y., Stinus L., Le Moal M., and Cador M. Evidence for selective involvement of dopamine in D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of d-amphetamine. J. Pharmacol. Exp. Ther. 277 (1996) 1177-1187
7. Blaha C.D., Coury A., Fibiger H.C., and Phillips A.G. Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis. Neuroscience 34 (1990) 699-705
8. Cador M., Revet J.-M., Kelley A.E., LeMoal M., and Stinus L. Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res. 486 (1989) 357-363
9. Carraway R., and Leeman S.E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 248 (1973) 6854-6861
10. Carraway R., and Leeman S.E. The amino acid sequence of a hypothalamic peptide, neurotensin. J. Biol. Chem. 250 (1975) 1907-1911
11. Dallvechia-Adams S., Smith Y., and Kuhar M.J. CART peptide-immunoreactive projection from the nucleus accumbens targets substantia nigra pars reticulata neurons in the rat. J. Comp. Neurol. 434 (2001) 29-39
12. Elliot P.J., and Nemeroff C.B. Repeated neurotensin administration in the ventral tegmental area: effects on baseline and d-amphetamine-induced locomotor activity. Neurosci. Lett. 68 (1986) 239-245
13. Floresco S.B., West A.R., Ash B., Moore H., and Grace A.A. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat. Neurosci. 6 (2003) 968-973
14. Geisler S., and Zahm D.S. Afferents of the ventral tegmental area in the rat-Anatomical substratum from integrative functions. J. Comp. Neurol. 490 (2005) 270-294
15. Geisler, S., Zahm, D.S., in press. Neurotensin afferents of the ventral tegmental area in the rat: [1] re-examination of the origins and [2] responses to acute psychostimulant and antipsychotic drug administration. Eur. J. Neurosci.
16. Geisler, S., Bérod, A., Zahm, D.S., Rostène, W., in press. Brain neurotensin, psychostimulants and stress. Peptides.
17. Glimcher P.W., Margolin D.H., Giovino A.A., and Hoebel B.G. Neurotensin: a new "reward" peptide. Brain Res. 291 (1984) 119-124
18. Glimcher P.W., Giovino A.A., and Hoebel B.G. Neurotensin self-injection in the ventral tegmental area. Brain Res. 403 (1987) 147-150
19. Hökfelt T., Everitt B.J., Theodorsson-Norheim E., and Goldstein M. Occurrence of neurotensin-like immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J. Comp. Neurol. 222 (1984) 543-559
20. Horger B.A., Taylor J.R., Elsworth J.D., and Roth R.H. Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization. Neuropsychopharmacology 11 (1994) 215-222
21. Innis R.B., Andrade R., and Aghajanian G.K. Substance K excites dopaminergic and non-dopaminergic neurons in rat substantia nigra. Brain Res. 335 (1985) 381-383
22. Itoh Z., Akiva K., Nomura S., Mizuno N., Hakamura Y., and Sugimoto T. Application of a coupled oxidation reaction to electron microscopic demonstration of horseradish peroxidase: cobalt-glucose oxidase method. Brain Res. 175 (1979) 341-347
23. Jennes L., Stumpf W.E., and Kalivas P.W. Neurotensin: topographical distribution in rat brain by immunohistochemistry. J. Comp. Neurol. 210 (1982) 211-224
24. Jones S., Kornblum J.L., and Kauer J.A. Amphetamine blocks long-term synaptic depression in the ventral tegmental area. J. Neurosci. 20 (2000) 5575-5580
25. Kalivas P.W., and Alesdatter J.E. Involvement of N-methyl-d-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267 (1993) 486-495
26. Kalivas P.W., and Duffy P. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J. Neurosci. 10 (1990) 2940-2949
27. Kalivas P.W., and Taylor S. Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area. Brain Res. 358 (1985) 70-76
28. Kalivas P.W., Burgess S.K., Nemeroff C.B., and Prange Jr. A.J. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience 8 (1983) 3495-3505
29. Kelley A.E. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 44 (2004) 161-179
30. Laitinen K., Crawley J.N., Mefford I.N., and De Witte P. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens. Brain Res. 523 (1990) 342-346
31. Leontovich T.A., and Zhukova G.P. The specificity of the neuronal structure and topography of the reticular formation in the brain and spinal cord of carnivora. J. Comp. Neurol. 121 (1963) 347-379
32. Lewis B.L., and O'Donnell P. Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'up' states in pyramidal neurons via D1 dopamine receptors. Cereb. Cortex 10 (2000) 1168-1175
33. Litwin L.C., and Golstein J.M. Effects of neurotensin on midbrain dopamine neuronal activity. Drug Dev. Res. 32 (1994) 6-12
34. McBride W.J., Murphy J.M., and Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav. Brain Res. 101 (1999) 129-152
35. Nauta W.J.H. Hippocampal projections and related neural pathways to the mid-brain in the cat. Brain 8 (1958) 319-341
36. Oades R.D., and Halliday G.M. Ventral tegmental (A10) system: neurobiology: 1. Anatomy and connectivity. Brain Res. Rev. 12 (1987) 117-165
37. Overton P.G., and Clark D. Burst firing in midbrain dopaminergic neurons. Brain Res. Rev. 25 (1997) 312-334
38. Panayi F., Dorso E., Lambas-Senas L., Renaud B., Scarna H., and Bérod A. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral responses to d-amphetamine. Neuropsychopharmacology 26 (2002) 64-74
39. Panayi F., Colussi-Mas J., Lambas-Senas L., Renaud B., Scarna H., and Bérod A. Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization. Neuropsychopharmacology 30 (2005) 871-879
40. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. fourth ed. (1998), Academic Press, San Diego
41. Phillipson O.T. Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: a horseradish peroxidase study in the rat. J. Comp. Neurol. 187 (1979) 85-98
42. Pinnock R.D. Neurotensin depolarizes substantia nigra dopamine neurones. Brain Res. 388 (1985) 151-154
43. Ramón-Moliner E., and Nauta W.J.H. The isodendritic core of the brainstem. J. Comp. Neurol. 126 (1966) 311-366
44. Rebec G.V., Grabner C.P., Johnson M., Pierce R.C., and Bardo M.T. Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience 76 (1997) 707-714
45. Rebec G.V., Christensen J.C.R., Guerra C., and Bardo M.T. Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty. Brain Res. 776 (1997) 61-67
46. Reynolds, S.M., Geisler, S., Bérod, A., Zahm, D.S., in press. Neurotensin antagonist acutely and robustly attenuates locomotion that accompanies stimulation of a neurotensin-containing pathway from rostral basal forebrain to the ventral tegmental area. Eur. J. Neurosci.
47. Rivest R., Jolicoeur F.B., and Marsden C.A. Neurotensin causes a greater increase in the metabolism of dopamine in the nucleus accumbens than in the striatum in vivo. Neuropharmacology 30 (1991) 25-33
48. Rompré P.-P. Psychostimulant-like effect of central microinjection of neurotensin on brain stimulation reward. Peptides 16 (1995) 1417-1420
49. Rompré P.-P., and Gratton A. A comparison of the effects of mesencephalic injections of neurotensin (1-13) and neuromedin N on brain electrical stimulation. Peptides 13 (1992) 713-719
50. Rompré P.-P., and Perron S. Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization. Neuropharmacology 39 (2000) 1880-1892
51. Rompré P.-P., Bauco P., and Gratton A. Facilitation of brain stimulation reward by mesencephalic injections of neurotensin (1-13). Eur. J. Pharmacol. 211 (1992) 295-303
52. Rostène W.H., and Alexander M.J. Neurotensin and neuroendocrine regulation. Front. Endocrinol. 18 (1997) 115-173
53. Saal D., Dong Y., Bonci A., and Malenka R. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37 (2003) 577-582
54. Saper C.B., Swanson L.W., and Cowan W.M. An autoradiographic study of the efferent connections of the lateral hypothalamic area in the rat. J. Comp. Neurol. 83 (1979) 689-706
55. Schultz W. Predictive reward signal of dopamine neurons. J. Neurophysiol. 80 (1998) 1-27
56. Schultz W., Dayan P., and Montague P.R. A neural substrate of prediction and reward. Science 275 (1997) 1593-1599
57. Schultz W., Tremblay L., and Hollerman J.R. Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 37 (1998) 421-429
58. Seutin V., Massotte L., and Dresse A. Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro. Neuropharmacology 28 (1989) 949-954
59. Shi W.S., and Bunney B.S. Neurotensin attenuates dopamine D2 agonist quinpirole-induced inhibition of midbrain dopamine neurons. Neuropharmacology 29 (1990) 1095-1097
60. Simmons J.M., Ackermann R.F., and Gallistel C.R. Medial forebrain bundle lesions fail to structurally and functionally disconnect the ventral tegmental area from many ipsilateral forebrain nuclei: implications for the neural substrate of brain stimulation reward. J. Neurosci. 18 (1998) 8515-8533
61. Sorg B.A., and Ulibarri C. Application of a protein-synthesis inhibitor into the ventral tegmental area, but not the nucleus accumbens, prevents behavioral sensitization to cocaine. Synapse 20 (1995) 2124-2172
62. Sotty F., Souliere F., Brun P., Chouvet G., Steinberg R., Soubrie P., Renaud B., and Suaud-Chagny M.F. Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: a combined in vivo electrochemical and electrophysiological study. Neuroscience 85 (1998) 1173-1182
63. Spanagel R., and Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22 11 (1999) 521-527
64. Steinberg R., Brun P., Fournier M., Souilhac J., Rodier D., Moss G., Terranova J.P., Le Fur G., and Soubrie P. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behavior and changes in dopaminergic transmission. Neuroscience 59 (1994) 921-929
65. Steinberg R., Brun P., Souilhac J., Brogault I., Leyris R., Le Fur G., and Soubrie P. Neurochemical and behavioral effects of neurotensin vs. [D-Tyr11] neurotensin on mesolimbic dopaminergic function. Neuropeptides 28 (1995) 43-50
66. Stewart J., and Vezina P. Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495 (1989) 401-406
67. Swanson L.W. An autoradiographic study of the efferent connections of the preoptic region in the rat. J. Comp. Neurol. 167 (1976) 227-256
68. Swanson L.W., Mogenson G.J., Gerfen C.R., and Robinson P. Evidence for a projection from the lateral preoptic area and substantia innominata to the 'mesencephalic locomotor region' in the rat. Brain Res. 295 (1984) 161-178
69. Ungless M.A., Whistler J., Malenka R.C., and Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411 (2001) 583-586
70. Werkman T.R., Kruse C.G., Nievelstein H., Long S.K., and Wadman W.J. Neurotensin attenuates the quinpirole-induced inhibition of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area. Neuroscience 95 (2000) 417-423
71. White F.J. Synaptic regulation of mesocorticolimbic dopamine neurons. Annu. Rev. Neurosci. 19 (1996) 405-436
72. White F.J., and Wang R.Y. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopaminergic neurons. Science 22 (1983) 1054-1057
73. Woulfe J., and Beaudet A. Immunocytochemical evidence for direct connections between neurotensin-containing axons and dopaminergic neurons in the rat ventral midbrain tegmentum. Brain Res. 479 (1989) 402-406
74. Woulfe J., and Beaudet A. Neurotensin terminals form synapses primarily with neurons lacking detectable tyrosine hydroxylase immunoreactivity in the rat substantia nigra and ventral tegmental area. J. Comp. Neurol. 321 (1992) 163-176
75. Zahm D.S., Williams E.A., Krause J.E., Welch M.A., and Grosu D.S. Distinct and interactive effects of d-amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat. J. Comp. Neurol. 400 (1998) 487-503
76. Zahm D.S., Grosu S., Williams E.A., Qi S., and Bérod A. Neurons of origin of the neurotensinergic plexus enmeshing the ventral tegmental area in rat: retrograde labeling and in situ hybridization combined. Neuroscience 104 (2001) 841-851
77. Zahm D.S., Geisler S., Nonneman R., and Williams E.A. The neurotensinergic plexus enmeshing ventral mesencephalic dopamine neurons in rat: lesion studies. Soc. Neurosci. Abstr. (2003) Program #600.9